748P Prognostic factors related to post-platinum atezolizumab for relapsed metastatic urothelial cancer (mUC) from the SAUL study.
Saved in:
| Title: | 748P Prognostic factors related to post-platinum atezolizumab for relapsed metastatic urothelial cancer (mUC) from the SAUL study. |
|---|---|
| Authors: | Bamias, A.1 (AUTHOR), Merseburger, A.2 (AUTHOR), Loriot, Y.3 (AUTHOR), James, N.4 (AUTHOR), Choy, E.5 (AUTHOR), Castellano Gauna, D.6 (AUTHOR), Lopez-Rios, F.7 (AUTHOR), Calabro, F.8 (AUTHOR), Kramer, M.W.9 (AUTHOR), de Velasco, G.6 (AUTHOR), Zakopoulou, R.10 (AUTHOR), Tzannis, K.1 (AUTHOR), Sternberg, C.N.11 (AUTHOR) |
| Source: | Annals of Oncology. 2020 Supplement 4, Vol. 31, pS581-S581. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 152695355 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 748P Prognostic factors related to post-platinum atezolizumab for relapsed metastatic urothelial cancer (mUC) from the SAUL study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Bamias%2C+A%2E%22">Bamias, A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Merseburger%2C+A%2E%22">Merseburger, A.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Loriot%2C+Y%2E%22">Loriot, Y.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22James%2C+N%2E%22">James, N.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Choy%2C+E%2E%22">Choy, E.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Castellano+Gauna%2C+D%2E%22">Castellano Gauna, D.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lopez-Rios%2C+F%2E%22">Lopez-Rios, F.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Calabro%2C+F%2E%22">Calabro, F.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kramer%2C+M%2EW%2E%22">Kramer, M.W.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Velasco%2C+G%2E%22">de Velasco, G.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zakopoulou%2C+R%2E%22">Zakopoulou, R.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tzannis%2C+K%2E%22">Tzannis, K.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sternberg%2C+C%2EN%2E%22">Sternberg, C.N.</searchLink><relatesTo>11</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2020 Supplement 4, Vol. 31, pS581-S581. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152695355 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2020.08.820 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S581 Titles: – TitleFull: 748P Prognostic factors related to post-platinum atezolizumab for relapsed metastatic urothelial cancer (mUC) from the SAUL study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bamias, A. – PersonEntity: Name: NameFull: Merseburger, A. – PersonEntity: Name: NameFull: Loriot, Y. – PersonEntity: Name: NameFull: James, N. – PersonEntity: Name: NameFull: Choy, E. – PersonEntity: Name: NameFull: Castellano Gauna, D. – PersonEntity: Name: NameFull: Lopez-Rios, F. – PersonEntity: Name: NameFull: Calabro, F. – PersonEntity: Name: NameFull: Kramer, M.W. – PersonEntity: Name: NameFull: de Velasco, G. – PersonEntity: Name: NameFull: Zakopoulou, R. – PersonEntity: Name: NameFull: Tzannis, K. – PersonEntity: Name: NameFull: Sternberg, C.N. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2020 Supplement 4 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 31 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |